Slate Run Pharmaceuticals recalls
2 recall notices naming Slate Run Pharmaceuticals since January 2025, in United States. The most recent was published 4 Mar 2026.
Latest recalls (2)
- Slate Run Pharmaceuticals recalls Eptifibatide InjectionFDALabeling: Not Elsewhere Classified. The carton for Eptifibatide Injection 75 mg/100 mL states 75 mg/100 mL vial for weight-adjusted bolus dosing.…
- Slate Run Pharmaceuticals recalls Cinacalcet Hydrochloride Tablets 60 mg and 1 moreFDACGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.